MDI Medical Weight Loss & Aesthetics

Tirzepatide

What Is Tirepatide

TIRZEPATIDE, also known as (MOUNJARO), is GLP-1(Glucagon-Like Peptide-1) plus GIP(Glucose dependent Insulinotropic Polypeptide) medication recently approved by the FDA  for effective and long-term weight management. 

How Does Tirzepatide work?

Who can use Tirzepatide?

Anyone with BMI > 30, or other health conditions related to increased weight (HTN, high cholesterol, PCOS)

What are some Side Effects of Tirzepatide?

  • Nausea
  • Vomiting
  • Diarrhea
  • Stomach pain
  • Constipation
  • Upset stomach

Benefits of Tirzepatide

  • Weight reduction by up to 20-25%
  • Improves Fat/Lipid metabolism
  • Reduces Glycemic levels or Hgba1c Level 
  • Improves Insulin Sensitivity

Why Should I Choose TIZEPATIDE for Weight Loss?

  • Tirzepatide is the first and only approved single medication that activates GIP and GLP-1 receptors in the body.
  • Tirzepatide provides superior Hgb A1C reduction across all clinical trials compared to other medications.
  • Increased average weight loss across all clinical trials.